SCHEMBL625045

SCHEMBL625045

CC(=O)SCCCCCCCCCCCBr

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.43
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
POLB P06746 2/20 0.41
BLM P54132 2/20 0.41
ATM Q13315 1/20 0.41
PTGS2 P35354 2/20 0.40
CES2 O00748 1/20 0.34
TRPA1 O75762 1/20 0.33
CPB2 Q96IY4 1/20 0.32
GMNN O75496 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22521141 1.00 CYP2C19 (0.43) CYP2C19HDAC3HDAC4HDAC1HDAC2
SCHEMBL8427233 1.00 CYP2C19 (0.43) CYP2C19HDAC3HDAC4HDAC1HDAC2
SCHEMBL12177996 1.00 CYP2C19 (0.43) CYP2C19HDAC3HDAC4HDAC1HDAC2
SCHEMBL5502050 1.00 CYP2C19 (0.43) CYP2C19HDAC3HDAC4HDAC1HDAC2
SCHEMBL30504176 1.00 CYP2C19 (0.43) CYP2C19HDAC3HDAC4HDAC1HDAC2
SCHEMBL19194532 1.00 CYP2C19 (0.43) CYP2C19HDAC3HDAC4HDAC1HDAC2
SCHEMBL10484076 0.98
SCHEMBL7879535 0.90
SCHEMBL14478080 0.87 CYP2C19 (0.52) CYP2C19HDAC3HDAC4HDAC1HDAC2
SCHEMBL6871500 0.87 CYP2C19 (0.52) CYP2C19HDAC3HDAC4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225952-A1 ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2023-07-20 US claimed
US-20170150724-A1 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES MICROBION CORP (US) 2017-06-01 US claimed
US-9408393-B2 Bismuth-thiols as antiseptics for agricultural, industrial and other uses MICROBION CORPORATION (US) 2016-08-09 US claimed
US-20130224258-A1 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES MICROBION CORPORATION (US) 2013-08-29 US claimed
EP-2603083-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES Microbion Corporation (US) 2013-06-19 EP claimed
EP-2536406-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES Microbion Corporation (US) 2012-12-26 EP claimed
WO-2012021754-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES MICROBION CORPORATION (US) 2012-02-16 WO claimed
WO-2011097347-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES MICROBION CORPORATION (US) 2011-08-11 WO claimed
CN-122070151-A Nitric oxide generating/releasing medical device 斯特里莱国家有限公司 2026-05-19 CN disclosed
US-12622858-B2 Additives for coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2026-05-12 US disclosed
US-20260083127-A1 Thiolactone-Derived Compounds for Generating Nitric Oxide and Methods of Forming the Same STERILE STATE, LLC (US) 2026-03-26 US disclosed
US-20250311729-A1 NITRIC OXIDE PRECURSORS AND MULTI-COMPONENT COMPOSITIONS FOR FORMING THE SAME STERILE STATE, LLC (US) 2025-10-09 US disclosed
US-20250129487-A1 PRODUCTION METHOD FOR AMMONIA AND PRODUCTION DEVICE NISSAN CHEMICAL CORPORATION (JP) 2025-04-24 US disclosed
WO-2025078956-A1 NITRIC OXIDE GENERATING/RELEASING MEDICAL DEVICES STERILE STATE, LLC (US) 2025-04-17 WO disclosed
EP-2536406-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES Microbion Corporation (US) 2012-12-26 EP disclosed
WO-2012021754-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES MICROBION CORPORATION (US) 2012-02-16 WO disclosed
EP-2393491-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS Microbion Corporation (US) 2011-12-14 EP disclosed
WO-2011097347-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES MICROBION CORPORATION (US) 2011-08-11 WO disclosed
US-20110003001-A1 BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS MICROBION CORPORATION 2011-01-06 US disclosed
WO-2010091124-A2 BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS MICROBION CORPORATION (US) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170150724-A1 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES TST, BTD, BTF3 CYP2C19 3079/4885HDAC3 2251/4885HDAC4 2265/4885
US-20110003001-A1 BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS TST, BTD, BTF3 CYP2C19 3378/4885HDAC3 2044/4885HDAC4 1980/4885
US-12622858-B2 Additives for coloring agents and methods of use thereof SLC25A20, NDUFA10, GAPDH CYP2C19 679/4885HDAC3 381/4885HDAC4 521/4885
US-20260083127-A1 Thiolactone-Derived Compounds for Generating Nitric Oxide and Methods of Forming the Same NOS1, NOS3, NOS2 CYP2C19 439/4885HDAC3 3856/4885HDAC4 4459/4885
US-20250311729-A1 NITRIC OXIDE PRECURSORS AND MULTI-COMPONENT COMPOSITIONS FOR FORMING THE SAME NOS1, NOS2, NOS3 CYP2C19 242/4885HDAC3 3941/4885HDAC4 3769/4885
US-20130224258-A1 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES TST, BTD, BTF3 CYP2C19 3079/4885HDAC3 2251/4885HDAC4 2265/4885
US-20230225952-A1 ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF COXFA4L2, TYR, OAT CYP2C19 2639/4885HDAC3 709/4885HDAC4 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.